CliffBio
small molecule

BEVESPI AEROSPHERE

FORMOTEROL FUMARATE; GLYCOPYRROLATE

Loss of exclusivityMarch 2031latest FDA-listed patent expiry
CompanyASTRAZENECA PHARMACEUTICALS LP

Drug detail

Brand nameBEVESPI AEROSPHERE
Active ingredientFORMOTEROL FUMARATE; GLYCOPYRROLATE
Strength0.0048MG/INH;0.0090MG/INH
Dosage formAEROSOL, METERED
RouteINHALATION
ModalitySmall molecule
FDA approvalApril 2016
Marketing statusRX

Listed patents

PatentExpiresType
8815258March 2031use U-2889
10716753May 2030product
9415009May 2030use U-2889
8324266May 2030use U-2889
8808713May 2030product
9463161May 2030product
8703806May 2030use U-2889

More from ASTRAZENECA PHARMACEUTICALS LP

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

BEVESPI AEROSPHERE patent cliff — loss of exclusivity March 2031 | CliffBio